mk571 mrp1 glutathione efflux

mk571 mrp1 glutathione efflux Multidrug resistance protein (MRP) 1/4 inhibitor MK-571 blunts Genomic discovery and functional validation

Name: mk571 mrp1 glutathione efflux Multidrug resistance protein (MRP) 1/4 inhibitor MK-571 blunts Genomic discovery and functional validation
Brand: jacksfamilyfund.org
SKU: 95747629403
Price: 20.64 USD
Availability: InStock
Rating: 4.5049 (25 reviews)

Genomic discovery and functional validation of MRP1 as a novel fetal hemoglobin modulator and potential therapeutic target in sickle cell disease medRxiv Transport of glutathione and glutathione conjugates by MRP1 ScienceDirect Nitrogen monoxide (NO) mediated iron release from cells is linked to NO induced glutathione efflux via multidrug resistance associated protein 1 PNAS GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulators Hanssen 2022 The FEBS Journal Wiley Online Library The Relationship of Glutathione S Transferase and Multi Drug Resistance Related Protein 1 in Nitric Oxide (NO) Transport and Storage PMC Glutathione S transferase and MRP1 form an integrated system involved in the storage and transport of dinitrosyldithiolato iron complexes in cells ScienceDirect

SKU: 95747629403 · From jacksfamilyfund.org

4.5

USD20.64 USD68.64

Pay in 4 interest-free payments of $5.16 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

Fungal Genet Biol 49:160172 Borodina I, Kenny LC, McCarthy CM, Paramasivan K, Pretorius E, Roberts TJ, van der Hoek SA, Kell DB (2020) The biology of ergothioneine, an antioxidant nutraceutical

A major safety concern is supine hypertension, and dosing should be avoided within 4 hours of bedtime

LegaardGELyngbaekMPPAlmdalTPDurrerCGNystrupULarsenELet al

People exposed to high pollution, UV radiation, or environmental toxins

Yoon et al., 2012

In other patient-oriented research, we have developed a biorepository linked to clinical phenotype data on a variety of movement disorders to act as a resource for ongoing and future biomarker and genetic studies